R. Palmer Beasley

from Wikipedia, the free encyclopedia

Robert Palmer Beasley (born April 29, 1936 in Los Angeles , California , † August 25, 2012 in Houston , Texas ) was an American epidemiologist who became known for his research on hepatitis .

Career

Beasley was at the University of Washington and a professor at the University of California, San Francisco before becoming Ashbel Smith Professor at the University of Texas School of Medicine in Houston. There he was Dean of the School of Public Health since 1987. In 2004 he retired.

He played a leading role in the development (in field studies in Taiwan) and global enforcement (at WHO) of a hepatitis B vaccine , which the WHO classified as the first anti-cancer vaccine. Beasley also demonstrated the transmission of hepatitis B from mother to child during pregnancy. This is one of the main infection mechanisms for hepatitis B in Asia (40 to 50% of infections). Beasley also examined the role of hepatitis B as the main cause of liver cancer. He researched the connection between liver cancer and hepatitis, which was very controversial at the time, in Taipei, Taiwan, in the 1970s as head of a research group at the University of Washington Medical School. Together with Luyu Huang, he conducted a study on 22,000 government employees in Taiwan. The researchers found a sixty-fold increased risk of liver cancer in chronic hepatitis B infection.

Robert Beasley was also involved in the fight against other infectious diseases such as SARS , serving as an advisor to the government in Taiwan.

Prices

Web links